Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VGX Pharmaceuticals
Plymouth Meeting, Pennsylvania, United Statesinovio.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Prior to its acquisition by Inovio Biomedical in June 2009, VGX Pharmaceuticals developed a broad pipeline focused on synthetic DNA vaccines and small molecule drugs targeting infectious diseases and immune-related conditions. Its lead assets included PENNVAX-B™ preventive HIV vaccine using electroporation delivery technology; universal influenza vaccines; therapeutic vaccines against HPV/cervical dysplasia/cancer using SynCon™ technology; small molecule immunomodulators such as VGX‑1027 which completed Phase I trials. The company also had animal health products through its majority-owned subsidiary. After merging with Inovio Biomedical Corp., all R&D activities continued under the combined entity’s expanded portfolio leveraging both companies’ proprietary platforms and technologies.
- Therapeutic areas
- ImmunologyOtherOncologyNeurologyInfectious Diseases
- Modalities
- DNA vaccinesSmall moleculesBiologicsGene therapy
- Industry
- Biotech
02
Partnerships
HIV Vaccines Trial Network collaboration on PENNVAX-B programNIH National Institute of Allergy and Infectious Diseases grant fundingADViSYS acquisition brought additional partnerships/manufacturing capabilitiesOther academic/government collaborations typical but not individually listed.
Beyond the preview
Go deeper on VGX Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VGX Pharmaceuticals.